Pluri (PLUR) Operating Margin Growth (1y) (2012 - 2025)
Pluri (PLUR) Operating Margin Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -1,651.00 |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | -60,640.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -60,640.00 |
| Sep 30, 2025 | -41,502.00 |
| Jun 30, 2025 | 462,185.00 |
| Mar 31, 2025 | 652,973.00 |
| Dec 31, 2024 | 228,530.00 |
| Sep 30, 2024 | 836,293.00 |
| Jun 30, 2024 | -38,992.00 |
| Mar 31, 2024 | 36,655.00 |
| Dec 31, 2023 | 32.90 Mn |
| Sep 30, 2023 | -199,994.00 |
| Mar 31, 2023 | -368,442.00 |
| Dec 31, 2019 | -1.10 Mn |
| Dec 31, 2018 | 27,200.00 |
| Dec 31, 2015 | 647,900.00 |
| Sep 30, 2015 | 10,526.00 |
| Dec 31, 2014 | 72,526.00 |
| Sep 30, 2014 | -80,316.00 |
| Jun 30, 2014 | -344,098.00 |
| Mar 31, 2014 | -671,754.00 |
| Dec 31, 2013 | -485,328.00 |